What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-04-13 compared with 2025-05-02 · 65 added, 9 removed, 10 unchanged (88% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity

Market Information and Holders

Our common stock is quoted on the OTC Pink Markets

under the symbol “EDGM”.

As of April 30, 2025, the last reported sale price of our common stock as reported by the OTC Markets

was $0.0035 per share.

Any over the counter market quotation reflects inter-dealer prices, without retail mark-up, mark-down or commission

and may not necessarily represent actual transactions.

As of April 30, 2025, there were approximately 200 shareholders of record.

number does not include beneficial owners whose shares are held in the names of various securities brokers, dealers and registered clearing

Our common stock is quoted on the OTCID Basic

Market under the symbol “EDGM.” As of April 10, 2026, the last reported sale price of our common stock as reported by the

OTC Markets was $.0055 per share.

Any over the counter market quotation reflects inter-dealer prices, without retail mark-up, mark-down

or commission and may not necessarily represent actual transactions.

As of December 31, 2025, there were approximately 198 shareholders

This number does not include beneficial owners whose shares are held in the names of various securities brokers, dealers and

registered clearing agencies.

The following table sets forth for the periods

indicated, high and low sales prices of the Company’s common stock as reported by the OTCID Basic Market.

Fiscal Year Ended December 31, 2025

Fourth Quarter

Third Quarter

Second Quarter

First Quarter

Fiscal Year Ended December 31, 2024

Fourth Quarter

Third Quarter

Second Quarter

First Quarter

The Company has not paid dividends on its common

7 unchanged sentences

Recent Sales of Unregistered Securities

In addition to the equity securities sold by the

Company that were previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company, the following

sales of equity securities during the period covered by this Report that were not registered under the Securities Act are disclosed below:

On October 7, 2025, the Company issued 6,666,667

shares of restricted common stock to an accredited investor pursuant to a subscription agreement between the Company and the investor

dated October 7, 2025.

The 6,666,667 shares of restricted common stock were issued pursuant to an exemption from registration under

Section 4(a)(2) of the Securities Act.

In October 2025, the Company issued an aggregate

of 16,826,087 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally

issued on September 17, 2021.

The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the

Securities Act.

On November 4, 2025, the Company issued 1,833,333

shares of restricted common stock to a service provider pursuant to a services agreement between the Company and the services provider

dated October 31, 2025.

The 1,833,333 shares of restricted common stock were issued pursuant to an exemption from registration under

Section 4(a)(2) of the Securities Act.

On November 26, 2025, the Company entered into

a securities purchase agreement with an accredited investor dated November 18, 2025.

Pursuant to the securities purchase agreement, the

Company sold to the accredited investor a convertible promissory note in the principal amount of $143,750 for which the Company received

net proceeds of $125,000.

The Company also issued to the accredited investor 1,250,000 shares of the Company’s common stock as commitment

The unsecured original issue discount promissory note and shares were issued in a private placement in reliance upon an exemption

from registration provided by Section 4(a)(2) of the Securities Act.

In November 2025, the Company issued an aggregate

of 96,332,497 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally

issued on September 17, 2021.

The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the

Securities Act.

In December 2025, the Company issued an aggregate

of 7,892,519 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally

issued on September 17, 2021.

The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the

Securities Act.

Under the terms of the respective employment agreements

of Charles Faulkner and Simon Wajcenberg, Mr.

Faulkner and Mr.

Wajcenberg each had accrued salaries of $386,000 as of October 31, 2025

(each an “Accrued Salary”).

On December 10, 2025, in full satisfaction of the entirety of the Accrued Salary for each of Mr.

Faulkner and Mr.

Wajcenberg, the Company issued 1 share of Series D Preferred Stock to each of Charles Faulkner and Simon Wajcenberg.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity